The Medical University of South Carolina   Medical Center  ·  College of Medicine ·  Directory   
Department of Pathology Banner MUSC Logo

Our Mission

To serve patients, health care providers, research scientists, scholars, and society by providing excellence and innovation in diagnostic services and educational resources in a respectful, professional and culturally diverse atmosphere.

Our Vision

To become a preeminent leader in academic anatomic and clinical pathology while translating basic science discovery to improved clinical care.

John Lazarchick, M.D. - Director, Hematology and Hematopathology Fellowship Program

John Lazarchick, M.D.

Vice Chair, Laboratory Medicine
Director, Hematology and Hematopathology Fellowship Program
Department of Pathology & Laboratory Medicine
Office: Children's Hospital Room 326C
Phone: (843) 792-3424
Fax: (843) 792-4811


Coagulation Inhibitors
Platelet Antibodies


B.A., 1964, Lafayette College, Easton, Pennsylvania
M.D., 1968, Thomas Jefferson University, Philadelphia, Pennsylvania
Internship: 1968-1969, Los Angeles County USC Medical Center
Medical Residency: 1969-1971, Mayo Clinic, Rochester, Minnesota
Hematology Fellowship: 1971-1972, Massachusetts General Hospital Harvard Medical School
National Hemophilia Foundation Research Fellowship: 1975-1977, University of Connecticut Health Center


Neonatal Alloimmune Thrombocytopenia
Pregnancy-related Hypercoagulability


  1. Skorupa A, Chaudhary U, Lazarchick J. Cold agglutinin disease with anti-Pr specificity in aggressive NK cell leukemia. Amer J Hematology, 2007.
  2. VanElls B, Lazarchick J. Lymphoplasmacytic lymphoma presenting as malignant ascites. Leukemia and Lymphoma. 47 (11): 2406-8, Nov. 2006.
  3. Onitilo AA, Skorupa A, Lal A, Ronish E, Mercier RJ, Lazarchick J. Rituximab in the treatment of acquired factor VIII inhibitors. Thombosis & Haemostasis. 96(1):84-7, Jul 2006.
  4. Sawhney R, McRae B, Lazarchick J. A rare case of multifocal extra-adrenal myelolipoma with markedly hypocellular bone marrow. Annals of Clinical and Laboratory Science. 36(2):208-11, 2006.
  5. Onitilo AA, Kio EA, Singh AK, Lazarchick J. Cytogenetic remission with imatinib therapy in hypereosinophilic syndrome with trisomy 8 and resolution of severe cardiac dysfunction. Leukemia and Lymphoma 46(11):1167-70, Nov. 2005.

Carroll A. Campbell, Jr. Neuropathology Laboratory (Brain Bank)

Department of Pathology and Laboratory Medicine Chairman Dr. Steven L. Carroll
Message from the Chairman


Upcoming Events

Copyright 2011 MUSC Department of Pathology and Laboratory Medicine